5-iminodaunorubicin has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glazer, RI; Johnston, JB; Kerrigan, D; Lloyd, LS; Zwelling, LA | 1 |
| Glazer, RI; Hartman, KD; Richardson, CL | 1 |
2 other study(ies) available for 5-iminodaunorubicin and Colonic Neoplasms
| Article | Year |
|---|---|
Comparison of DNA scission and cytotoxicity produced by Adriamycin and 5-iminodaunorubicin in human colon carcinoma cells.
Topics: Cell Survival; Cells, Cultured; Colonic Neoplasms; Daunorubicin; DNA; DNA Repair; DNA, Single-Stranded; Dose-Response Relationship, Drug; Doxorubicin; Humans; Kinetics | 1983 |
Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.
Topics: Cell Survival; Cells, Cultured; Colonic Neoplasms; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; Molecular Weight; Neoplasms, Experimental; RNA, Neoplasm | 1982 |